Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma.
Santoro A, Magagnoli M, Spina M, Pinotti G, Siracusano L, Michieli M, Nozza A, Sarina B, Morenghi E, Castagna L, Tirelli U, Balzarotti M.
Santoro A, et al. Among authors: siracusano l.
Haematologica. 2007 Jan;92(1):35-41. doi: 10.3324/haematol.10661.
Haematologica. 2007.
PMID: 17229633
Free article.
Clinical Trial.